Coronavirus company news summary - Intelligent Fingerprinting creates saliva-based test - Cue Health gets approval for point-of-care test in India - Verdict Medical Devices
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – Intelligent Fingerprinting creates saliva-based test – Cue Health gets approval for point-of-care test in India

15 Jul 2021

Intelligent Fingerprinting has created a saliva-based lateral flow test (LFT) to quickly identify Covid-19 antigens. Current tests for Covid-19 involve the invasive nose and throat swabs but the new test requires a swab of a saliva sample from inside the cheek, making testing easier for all ages, the company said. The test strip has a simple design with minimal plastic use. Meant to enable regular testing even in public spaces such as schools and airports, the new test provides results in 20 minutes.

Cue Health has obtained approval from India’s Central Drugs Standard Control Organisation (CDSCO) for professional use of its point-of-care Covid-19 test. The portable test is designed to deliver results to linked mobile smart devices in approximately 20 minutes. It can also detect emerging variants of the Covid-19 virus. Cue’s digital platform facilitates end-to-end integrated reporting of results. The test already received authorisation in the US, EU and Canada.

Hologic has secured the European CE mark to use saliva samples with its Aptima SARS-CoV-2 assay, a molecular diagnostic test to identify the genetic material from the Covid-19 virus. Run on the automated Panther system, the assay holds CE mark for nasopharyngeal and nasal swabs usage among other types of specimens. The company boosted production capacity to make Aptima tests in large volumes, with more than 100 million of these tests shipped globally since last year.